Amundi
GH icon

Amundi’s Guardant Health GH Stock Holding History

Amundi’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Buy
16,729
+5,147
+44% +$560K ﹤0.01% 1133
2026
Q1 		$1.07M Buy
11,582
+6,571
+131% +$660K ﹤0.01% 1270
2025
Q4 		$512K Buy
+5,011
New +$448K ﹤0.01% 1468
2025
Q2 		– Sell
-33
Closed -$1.39K – 1870
2025
Q1 		$1.39K Buy
33
+22
+200% +$949 ﹤0.01% 1997
2024
Q4 		$402 Buy
+11
New +$309 ﹤0.01% 2120
2023
Q4 		– Sell
-666
Closed -$18K – 2028
2023
Q3 		$18K Sell
666
-36,450
-98% -$1.28M ﹤0.01% 1938
2023
Q2 		$1.31M Sell
37,116
-16,008
-30% -$460K ﹤0.01% 1232
2023
Q1 		$1.25M Buy
53,124
+2,926
+6% +$83.6K ﹤0.01% 1230
2022
Q4 		$1.54M Buy
50,198
+7,527
+18% +$344K ﹤0.01% 1241
2022
Q3 		$2.55M Sell
42,671
-159,053
-79% -$8.17M ﹤0.01% 1108
2022
Q2 		$9.69M Sell
201,724
-15,787
-7% -$782K 0.01% 780
2022
Q1 		$16M Sell
217,511
-134,007
-38% -$9.17M 0.01% 721
2021
Q4 		$27.7M Buy
351,518
+213,694
+155% +$22.1M 0.02% 603
2021
Q3 		$17.2M Buy
+137,824
New +$16.4M 0.01% 714

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Amundi's GH Position: Q2 2026 in Review

Amundi increased its Guardant Health (GH) stake by 44% in Q2 2026, buying an estimated $560K and bringing the position to 16,729 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

Amundi first reported a position in GH in Q3 2021 and has held it in 14 quarters since. The position peaked at $27.7M in Q4 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Amundi held 16,729 shares of Guardant Health worth $2.51M as of Q2 2026.
  • Amundi bought 5,147 Guardant Health shares in Q2 2026, an estimated $560K.
  • Guardant Health made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1133 holding.
  • Amundi first reported a position in Guardant Health in Q3 2021 and has held it in 14 quarters since.
  • Amundi's Guardant Health position peaked at $27.7M in Q4 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.